329 related articles for article (PubMed ID: 24878845)
1. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
[TBL] [Abstract][Full Text] [Related]
2. IL-10 alleviates lipopolysaccharide-induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts.
Shi J; Shi S; Xie W; Zhao M; Li Y; Zhang J; Li N; Bai X; Cai W; Hu X; Hu D; Han J; Guan H
J Cell Mol Med; 2021 Feb; 25(3):1554-1567. PubMed ID: 33410606
[TBL] [Abstract][Full Text] [Related]
3. IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways.
Shi J; Wang H; Guan H; Shi S; Li Y; Wu X; Li N; Yang C; Bai X; Cai W; Yang F; Wang X; Su L; Zheng Z; Hu D
Cell Death Dis; 2016 Mar; 7(3):e2133. PubMed ID: 26962683
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
Mu S; Kang B; Zeng W; Sun Y; Yang F
Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
[TBL] [Abstract][Full Text] [Related]
6. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
Tan M; Wu D; Zhou Y; Duan B
J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mTOR signaling.
Dong Y; Cao X; Huang J; Hu Z; Chen C; Chen M; Long Q; Xu Z; Lv D; Rong Y; Luo S; Wang H; Deng W; Tang B
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166887. PubMed ID: 37739092
[TBL] [Abstract][Full Text] [Related]
9. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.
Ray S; Ju X; Sun H; Finnerty CC; Herndon DN; Brasier AR
J Invest Dermatol; 2013 May; 133(5):1212-20. PubMed ID: 23303450
[TBL] [Abstract][Full Text] [Related]
10. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway.
Chen H; Xu K; Sun C; Gui S; Wu J; Wang S
An Bras Dermatol; 2023; 98(1):26-35. PubMed ID: 36272879
[TBL] [Abstract][Full Text] [Related]
12. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
13. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
Liu HW; Cheng B; Yu WL; Sun RX; Zeng D; Wang J; Liao YX; Fu XB
Life Sci; 2006 Jun; 79(5):475-83. PubMed ID: 16522324
[TBL] [Abstract][Full Text] [Related]
15. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro.
Zhi Y; Wang H; Huang B; Yan G; Yan LZ; Zhang W; Zhang J
Burns; 2021 Jun; 47(4):894-905. PubMed ID: 33143990
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
[TBL] [Abstract][Full Text] [Related]
17. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
18. Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A/ETV4 axis.
Yu Q; Dai Q; Huang Z; Li C; Yan L; Fu X; Wang Q; Zhang Y; Cai L; Yang Z; Xiao R
J Transl Med; 2023 Mar; 21(1):231. PubMed ID: 37004048
[TBL] [Abstract][Full Text] [Related]
19. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
